Our Partnership

Due to our leading role in treating cancer in the Middle east region. Cairo Cure became a part of an international 2nd opinion program conducted in the University of Nebraska Medical center (UNMC) which is known to be one of the most advanced centers in treating cancer in the world.

The idea of this program is to:

First: Electronic referral of our patients' data for consultation   on request. A reply to our consult is achieved within 48-72 hours. Video conferences with UNMC oncologists is also accessible via  this program.

Second: No cost  bone marrow transplant and cancer care training for Cairo Cure physicians and nurses at UNMC  in order to provide the state-of-the-art services for out patients.  

Till now, we had almost 50 mutual consultations between medical oncology, pathology, surgery and general medicine.

In the University of Nebraska Medical Center, The following services are provided:

Lymphoma Program
University of Nebraska Medical Center/Nebraska Health System is one of the most advanced centers in the U.S. for lymphoma treatment. We are world-renowned for diagnosis, therapy and research in lymphoma. Our lymphoma team consists of such internationally acclaimed specialists as James Armitage, MD; Philip Bierman, MD; R. Gregory Bociek, MD; and Julie M. Vose, MD, who are supported by highly trained coordinators. We are also treating rare forms of lymphoma that are confined to the skin. The two most common forms are cutaneous T-cell lymphoma (mycosis fungoides) and peripheral T-cell lymphoma. Patients are treated with rotational total skin electron beam therapy. This therapy has been effective in patients for whom other treatments have failed.
 

Oncology & Hematology
Our oncology and hematology programs provide expert treatment for all malignancies that occur in adults and children. Treatment may include chemotherapy and immunotherapy, including vaccines and radioimmunoconjugates. Hematology treats patients with blood diseases such as anemia, bleeding disorders and clotting problems. This department is home to the Regional Hemophilia Treatment Center, which cares for adult and pediatric patients with bleeding disorders. It is a member of the National Comprehensive Cancer Network (NCCN), an alliance of the nation's 17 leading cancer centers. NCCN centers develop and set standards of care for the cancer treatment and perform outcome research to ensure the delivery of high quality, cost-effective services to cancer patients worldwide. Our nurses and support personnel are specialized in cancer care. The treatment area is open to patients 24 hours every day.
^top
 

Transplantation Programs
Elizabeth Reed, MD, heads UNMC/NHS bone marrow transplant programs. Our multidisciplinary transplantation team for adult and pediatric patients includes physicians, case managers, registered nurses, social workers, physical and occupational therapists, pharmacists, nutritionists, child-life specialists and more. Over the past 15 years, we have conducted more than 7,500 bone marrow, stem cell and solid organ transplants. High-dose therapy with bone marrow or peripheral stem cell transplantation is also available. We are proud of our peripheral stem cell transplantation program directed by Anne Kessinger, MD, who pioneered the technique. The team is known throughout the world for its transplantation expertise for a variety of diseases and has treated patients from every U.S. state and 23 countries. UNMC/NHS transplant center has fast become the destination of choice for well-informed international patients seeking bone marrow, stem cell and solid organ transplants, and cancer treatment.
 

Autologous Hematopoietic Stem Cell Transplantation
Over the years, the UNMC/NHS bone marrow transplantation program has been consistently ranked as one of the busiest adult and pediatric bone marrow transplant centers in the world. Established in 1983, it has been recognized internationally for pioneering autologous transplantation for lymphoma, using peripheral stem cells as an alternative rescue product, performing outpatient transplants and conducting groundbreaking studies on various growth factors. Broad services include high-dose therapy and autologous rescue for lymphoma, Hodgkin's disease, leukemia, neuroblastoma and such solid tumors as breast, testicular, ovarian and other cancers. More than 1,800 autologous bone marrow transplants have been performed here since 1989.
^top
 

Allogenic Hematopoietic Stem Cell Transplantation
We have offered related allogenic transplants to children and adults since 1983 and added unrelated allogenic bone marrow transplantation in 1988. We are constantly refining transplantation techniques to include work in peripheral blood stem cell transplants, better techniques for T-depletion of bone marrow, immunologic therapy after transplantation and immune reconstitution after peripheral stem cell transplantation. Our multidisciplinary team includes adult and pediatric physicians, case managers, registered nurses, social workers, physical and occupational therapists, nutritionists, child-life specialists and more. We have now performed more than 500 related and unrelated allogenic hematopoietic stem cell transplants at our center.

Prostate Cancer
Our radiation technology offers the latest options and a high probability of success for prostate cancer patients over the traditional prostatectomy. Our protocol includes:

a) Three-Dimensional Conformal Prostate Treatment.     
This technique involves using multiple beam therapy to provide higher doses of irradiation to the prostate, while limiting the dose to normal structures, such as the bladder and rectum. The increased prostate radiation doses possible with this technique have already demonstrated a 20- to 25-percent improvement in disease-free survival over standard techniques, with less risk of side effects. The 3-D conformal prostate program is further strengthened by the use of prostate ultrasound targeting (BAT) and intensity modulated radiation therapy (IMRT).

b) Prostate Brachytherapy.
This technique has been active in the treatment of prostate cancer with ultrasound guided radioactive seed implants. For many men with early stage prostate cancer, this treatment can be performed on an outpatient basis with excellent results and is very effective treatment for men concerned about potency preservation.


For more details contact: